Observational studyAntimicrobial agents and chemotherapy2025
Efficacy, safety, and population pharmacokinetics of a single 1500mg dose of dalbavancin for short-term therapy in patients with chronic prosthetic joint infections.
Eva Benavent et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.